Management of brain edema complicating stroke

Journal of Intensive Care Medicine

Volumn 16, Issue 3, 2001, Pages 128-141

  Rosand, Jonathan ^a   Schwamm, Lee H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL; MANNITOL; SODIUM CHLORIDE;

BRAIN BLOOD FLOW; BRAIN EDEMA; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; STROKE; SURGICAL APPROACH;

EID: 0035017142     PISSN: 08850666     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1489.2001.00128.x     Document Type: Review

References (104)

1. White O, Norris J, Hachinski V, et al. Death in early stroke, causes and mechanisms. Stroke 1979;10:743
2. Bounds JV, Wiebers DO, Whisnant JP, et al. Mechanisms and timing of deaths from cerebral infarction. Stroke 1981; 12:474-477
3. Davalos A, Castillo J. Progressing stroke. In: Fisher M, Bogousslavsky J, eds. Current review of cerebrovascular disease. Philadelphia: Current Medicine, 1999:149-160
4. Davalos A, Toni D, Iweins F, et al. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I. Stroke 1999;30:2631-2636
5. Hacke W, Schwab S, Horn M, et al. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996;53:309-315
6. Cushing H. Some clinical experiments and clinical observations concerning states of increased intracranial tension. Am J Med Sci 1902;124:375-400
7. Cardoso E, Kupchak J. Evaluation of intracranial pressure gradients by means of transcranial Doppler ultrasonography. Acta Neurochir 1992;55(suppl):1-5
8. Kaufmann G, Clark K. Continuous simultaneous monitoring of intraventricular and cervical subarachnoid cerebrospinal fluid pressure to indicate development of cerebral and tonsillar herniation. J Neurosurg 1970;33:145-150
9. Weaver D, Winn R, Jane J. Differential intracranial pressure in patients with unilateral mass lesions. J Neurosurg 1982; 56:660-665
10. Frank JI. Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 1995;45:1286-1290
11. Sette G, Baron JC, Mazoyer B, et al. Local brain haemodynamics and oxygen metabolism in cerebrovascular disease. Positron emission tomography. Brain 1989;112:931-951
12. Baron JC. Positron emission tomography. In: Barnett HJM, Mohr JP, Stein BM. et al., eds. Stroke: pathophysiology diagnosis and management. New York: Churchill Livingstone, 1998:101-119
13. Meyer JS, Shimazu K, Fukuuchi Y, et al. Impaired neurogenic cerebrovascular control and dysautoregulation after stroke. Stroke 1973;4:169-186
14. Hayman LA, Evans RA, Bastion FO, et al. Delayed high dose contrast CT: identifying patients at risk of massive hemorrhagic infarction. AJR 1981;136:1151-1159
15. Fishman R. Cerebrospinal fluid in diseases of the nervous system, 2nd ed. Philadelphia: WB Saunders, 1992
16. Hossman K. The pathophysiology of ischemic brain swelling. In: Inaba Y, Klatzo I, Spatz M, eds. Brain edema: proceedings of the sixth international symposium. New York: Springer-Verlag, 1985:367-384
17. Klatzo I. Pathophysiological aspects of brain edema. Acta Neuropathol 1987;72:236-239
18. Gotoh O, Asano T, Koide T, et al. Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I. The time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 1251-albumin. Stroke 1985;16:101-109
19. Betz AL, Ennis SR, Schielke GP, et al. Blood-to-brain sodium transport in ischemic brain edema. Adv Neurol 1990;52: 73-80
20. Klatzo I. Pathophysiological aspects of brain edema. In: Reulen HJ, Schurmann K, eds. Steroids and brain edema. New York: Springer-Verlag, 1972:1-8
21. Chester EM, Agamanolis DP, Banker BQ, et al. Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology 1978;28:928-939
22. Press MF. Lead encephalopathy in neonatal Long-Evans rats: morphologic studies. J Neuropathol Exp Neurol 1977; 36:169-193
23. Sundstrom R, Muntzing K, Kalimo H, et al. Changes in the integrity of the blood-brain barrier in suckling rats with low dose lead encephalopathy. Acta Neuropathol 1985;68: 1-9
24. Del Maestro RF, Megyesi JF, Farrell CL. Mechanisms of tumor-associated edema: a review. Can J Neurol Sci 1990; 17:177-183
25. Barzo P, Marmarou A, Fatouros P, et al. Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosurg 1997;87:900-907
26. Schaefer PW, Buonanno FS, Gonzalez RG, et al. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997; 28:1082-1085
27. Tomura N, Kurosawa R, Kato K, et al. Transient neurotoxicity associated with FK506: MR findings. J Comput Assist Tomogr 1998;22:505-507
28. Debaere C, Stadnik T, De Maeseneer M, et al. Diffusion-weighted MRI in cyclosporin A neurotoxicity for the classification of cerebral edema. Eur Radiol 1999;9:1916-1918
29. Reulen HJ, Schurmann K, eds. Steroids and brain edema. New York: Springer-Verlag, 1972
30. Ohnishi T, Sher PB, Posner JB, et al. Capillary permeability factor secreted by malignant brain tumor. Role in peritumoral brain edema and possible mechanism for anti-edema effect of glucocorticoids. J Neurosurg 1990;72:245-251
31. McComb JG. Cerebrospinal fluid, hydrocephalus, and cerebral edema. In: Davis RL, Robertson DM, eds. Textbook of neuropathology. Baltimore: Williams & Wilkins, 1997: 225-251
32. Brightman MW, Tao-Cheng JH. Tight junctions of brain endothelium and epithelium. In: Pardridge WM, ed. The blood-brain barrier: cellular and molecular biology. New York: Raven Press, 1993:107-126
33. Parent A. Carpenter's human neuroanatomy, 9th ed. Baltimore: Williams & Wilkins, 1996
34. Rosenberg GA. Ischemic brain edema. Prog Cardiovasc Dis 1999;42:209-216
35. Pardridge WM. Blood-brain barrier transport mechanisms. In: Welch KMA, Caplan LR, Reis DJ, et al., eds. Primer on cerebrovascular diseases. San Diego: Academic Press, 1997: 21-25
36. Macknight AD, Leaf A. Regulation of cellular. Physiol Rev 1977;57:510-573
37. Siesjo BK, Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab 1989;9:127-140
38. Baethmann A, Staub F. Cellular edema. In: Welch KMA, Caplan LR, Reis DJ, et al., eds. Primer on cerebrovascular disease. San Diego: Academic Press, 1997:153-156
39. Hatashita S, Hoff JT. Role of blood-brain barrier permeability in focal ischemic brain edema. Adv Neurol 1990;52: 327-333
40. Hatashita S, Hoff JT. Brain edema and cerebrovascular permeability during cerebral ischemia in rats. Stroke 1990;21: 582-588
41. Gartshore G, Patterson J, Macrae IM. Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp Neurol 1997;147: 353-360
42. Chan PH, Schmidley JW, Fishman RA, et al. Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology 1984;34:315-320
43. Chan PH, Fishman RA, Wesley MA, et al. Pathogenesis of vasogenic edema in focal cerebral ischemia. Role of superoxide radicals. Adv Neurol 1990;52:177-183
44. Chan PH, Yang GY, Chen SF, et al. Cold-induced brain edema and infarction are reduced in transgenic mice over-expressing CuZn-superoxide dismutase. Ann Neurol 1991; 29:482-486
45. Bell BA, Symon L, Branston NM. CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in baboons. J Neurosurg 1985;62:31-41
46. Betz AL, Keep RF, Beer ME, et al. Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia. J Cereb Blood Flow Metab 1994;14:29-37
47. Koudstaal PJ, Stibbe J, Vermeulen M. Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. BMJ 1988;297:1571-1574
48. Hatashita S, Hoff JT, Ishii S. Focal brain edema associated with acute arterial hypertension. J Neurosurg 1986;64: 643-649
49. Rordorf G, Cramer SC, Efird JT, et al. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997;28:2133-2138
50. Krieger DW, Demchuk AM, Kasner SE, et al. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke 1999;30:287-292
51. NINDSrt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587
52. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group [see comments]. N Engl J Med 1999;340: 1781-1787
53. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism [see comment]. JAMA 1999;282: 2003-2011
54. Slivka A, Murphy E, Horrocks L. Cerebral edema after temporary and permanent middle cerebral artery occlusion in the rat. Stroke 1995;26:1061-1066
55. Ropper AH, Shafran B. Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol 1984;41: 26-29
56. Schwab S, Aschoff A, Spranger M, et al. The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology 1996;47:393-398
57. Shenkin HA, Bezier HS, Bouzarth WF. Restricted fluid intake. Rational management of the neurosurgical patient. J Neurosurg 1976;45:432-436
58. Tietjen C, Hurn P, Ulatowski J, et al. Treatment modalities for hypertensive patients with intracranial pathology: options and risks. Crit Care Med 1996;24:311-322
59. Adams R, Powers W. Management of hypertension in acute intracerebral hemorrhage. Crit Care Clin 1997;13:131-161
60. Puchstein C, van Aken H, Hidding J, et al. Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions. Acta Neurochir 1983;67:283-290
61. Turner JM, Powell D, Gibson RM, et al. Intracranial pressure changes in neurosurgical patients during hypotension induced with sodium nitroprusside or trimetaphan. Br J Anaesth 1977;49:419-425
62. Cottrell JE, Gupta B, Rappaport H, et al. Intracranial pressure during nitroglycerin-induced hypotension. J Neurosurg 1980;53:309-311
63. Nishikawa T, Omote K, Namiki A, et al. The effects of nicardipine on cerebrospinal fluid pressure in humans. Anesth Analg 1986;65:507-510
64. Gaab MR, Hollerhage HG, Walter GF, et al. Brain edema, autoregulation, and calcium antagonism. An experimental study with nimodipine. Adv Neurol 1990;52:391-400
65. Johshita H, Asano T, Takara K. Effect of a calcium antagonist, nicardipine, on ischemic brain edema formation. In: Inaba Y, Klatzo I, Spatz M, eds. Brain edema. New York: Springer-Verlag, 1990:555-559
66. Vraamark T, Waldemar G, Strandgaard S, et al. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation. J Hypertens 1995;13:755-701
67. Cai H, Yao H, Ibayashi S, et al. Effects of long-acting angiotensin-converting enzyme inhibitor, imidapril, on the lower limit of cerebral blood flow autoregulation in hypertensive rats. Eur J Pharmacol 1998;341:73-77
68. Torup M, Waldemar G, Paulson OB. Ceranapril and cerebral blood flow autoregulation. J Hypertens 1993;11: 399-405
69. Waldemar G, Schmidt JF, Andersen AR, et al. Angiotensin converting enzyme inhibition and cerebral blood flow autoregulation in normotensive and hypertensive man. J Hypertens 1989;7:229-235
70. Waldemar G, Paulson OB. Angiotensin converting enzyme inhibition and cerebral circulation - a review. Br J Clin Pharmacol 1989;28:S177-S182
71. Waldemar G, Paulson OB, Barry DI, et al. Angiotensin converting enzyme inhibition and the upper limit of cerebral blood flow autoregulation: effect of sympathetic stimulation. Circ Res 1989;64:1197-1204
72. Schmidt JF, Andersen AR, Paulson OB, et al. Angiotensin converting enzyme inhibition, CBF autoregulation, and ICP in patients with normal-pressure hydrocephalus. Acta Neurochir 1990;106:9-12
73. Karibe H, Zarow GJ, Weinstein PR. Use of mild intraischemic hypothermia versus mannitol to reduce infarct size after temporary middle cerebral artery occlusion in rats. J Neurosurg 1995;83:93-98
74. Hartwell RC, Sutton LN. Mannitol, intracranial pressure, and vasogenic edema. Neurosurgery 1993;32:444-450
75. Javid M, Settlage P. Effect of urea on cerebrospinal fluid pressure in human subjects. JAMA 1956;160:943-949
76. Wise B, Chater N. The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebrospinal fluid pressure. J Neurosurg 1963;19:1038-1043
77. Cantore G, Guidetti B, Virno M. Oral glycerol for the reduction of intracranial pressure. J Neurosurg 1964;21:278-283
78. a'Rogvi-Hansen B, Boysen G. Glycerol for acute ischaemic stroke (Cochrane Review). In: The Cochrane Library. Oxford: Update Software, 1999
79. Node Y, Nakazawa S. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon. Adv Neurol 1990;52:359-363
80. Muizelaar JP, Wei EP, Kontos HA, et al. Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes. J Neurosurg 1983; 59:822-828
81. Rosner MJ, Coley I. Cerebral perfusion pressure: a hemodynamic mechanism of mannitol and the postmannitol hemogram. Neurosurgery 1987;21:147-156
82. Muizelaar JP, Lutz HA, Becker DP. Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg 1984;61: 700-706
83. Jafar J, Johns L, Mullan S. The effect of mannitol on cerebral blood flow. J Neurosurg 1986;64:754-759
84. Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992; 77:584-589
85. Manno EM, Adams RE, Derdeyn CP, et al. The effects of mannitol on cerebral edema after large hemispheric cerebral infarct. Neurology 1999;52:583-587
86. Malek A, Gross G, Jiang L, et al. Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. Stroke 1998;29:2631-2640
87. McManus ML, Churchwell KB, Strange K. Regulation of cell, in health and disease. N Engl J Med 1995;333:1260-1266
88. Zornow M. Hypertonic saline as a safe and efficacious treatment of intracranial hypertension. J Neurosurg Anesth 1996;8:175-177
89. Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline [see comments]. Crit Care Med 1998;26:1118-1122
90. Schwarz S, Schwab S, Bertram M, et al. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998;29:1550-1555
91. Schwab S, Spranger M, Schwarz S, et al. Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology 1997;48:1608-1613
92. Schwab S, Schwarz S, Spranger M, et al. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction [see comments]. Stroke 1998;29:2461-2466
93. Heros R. Cerebellar hemorrhage and infarction. Stroke 1982;13:166-169
94. Mathew P, Teasdale G, Bannan A, et al. Neurosurgical management of cerebellar hematoma and infarct. J Neurol Neurosurg Psychiatry 1995;59:287-292
95. Rieke K, Schwab S, Krieger D, et al. Decompressive surgery in space-occupying hemispheric infarction: results of an open, prospective trial. Crit Care Med 1995;23:1576-1587
96. Carter BS, Ogilvy CS, Candia GJ, et al. One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery 1997;40:1168-1175; discussion 1175-1176
97. Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998;29:1888-1893
98. Forsting M, Reith W, Schabitz WR, et al. Decompressive craniectomy for cerebral infarction. An experimental study in rats. Stroke 1995;26:259-264
99. Engelhorn T, Doerfler A, Kastrup A, et al. Decompressive craniectomy, reperfusion, or a combination for early treatment of acute "malignant" cerebral hemispheric stroke in rats? Potential mechanisms studied by MRI. Stroke 1999; 30:1456-1463
100. Krieger D, Hacke W. The intensive care of the stroke patient. In: Barnett H, Mohr J, Stein B, et al, eds. Stroke: pathophysiology, diagnosis, and management. Philadelphia: Churchill Livingstone, 1998:1133-1154
101. Berger L, Hakim AM. The association of hyperglycemia with cerebral edema in stroke. Stroke 1986;17:865-871
102. Rosenberg GA, Estrada EY. Atrial natriuretic peptide blocks hemorrhagic brain edema after 4-hour delay in rats. Stroke 1995;26:874-877
103. Hakamata Y, Ito U, Hanyu S, et al. Long-term high-colloid oncotic therapy for ischemic brain edema in gerbils. Stroke 1995;26:2149-2153
104. Schwarz S, Bertram M, Aschoff A, et al. Indomethacin for brain edema following stroke. Cerebrovasc Dis 1999;9: 248-250